Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis

clinical trial

Details

Instance of: clinical trial
Start time: 1 October 2013
End time: 28 February 2017
Country: France
Main subject: etanercept, arthritis
maximum age: 17
minimum age: 4
number of participants: 126
short name: Etaplus
study type: interventional study
title: Determination of the Effective Individual Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis

Nothing in the MetaHistoryBook collection references this item yet.